What is the level of liabilities of Zymeworks this year?
Zymeworks has a debt balance of 116.07 M USD this year.
Zymeworks Liabilities 2024
Zymeworks Liabilities
116.07 M USD
Ticker
ZYME
ISIN
CA98985W1023
WKN
A2DP0F
In 2024, Zymeworks's total liabilities amounted to 116.07 M USD, a -25.5% difference from the 155.8 M USD total liabilities in the previous year.
Zymeworks Aktienanalyse
What does Zymeworks do?
Zymeworks Inc is a biotechnology company that was founded in 2003. The company is headquartered in Vancouver, Canada. The founders of the company were a group of researchers specializing in the development of antibodies. Their goal was to develop a platform technology that allows for the design and production of highly specific and effective antibodies. Zymeworks Inc's platform technology is based on the use of protein engineering technologies such as Immunoglobulin G competences (IgG). This allows for the targeted production of antibodies that bind to specific target molecules. The business model of Zymeworks Inc is based on licensing its platform technology to other companies. The licensees use Zymeworks' platform to develop antibodies or other proteins for their own pharmaceutical research. Zymeworks Inc has various business areas that specialize in the different applications of its platform technology. This includes cancer immunotherapy, the treatment of autoimmune diseases, and the development of biological therapeutics. The company also offers products that can be used directly by patients, such as a test kit for determining the risk of breast cancer. Over the years, Zymeworks Inc has expanded its business areas and formed partnerships with major pharmaceutical companies. In summary, Zymeworks Inc is a leading biotechnology company specializing in the development of antibodies and other proteins. It has a unique platform technology that allows its customers to develop targeted antibodies and therapeutic proteins. Its products are used in various areas, including cancer immunotherapy, the treatment of autoimmune diseases, and biological therapeutics. Zymeworks ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Zymeworks's Liabilities
Zymeworks's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Zymeworks's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Zymeworks's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Zymeworks's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Zymeworks’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Zymeworks stock
What were the liabilities of Zymeworks compared to the previous year?
The liabilities of Zymeworks have increased by -25.5% dropped compared to the previous year.
What are the consequences of high debt for investors of Zymeworks?
High liabilities can pose a risk for investors of Zymeworks, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Zymeworks?
Low liabilities mean that Zymeworks has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Zymeworks affect the company?
An increase in liabilities of Zymeworks can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Zymeworks affect the company?
A decrease in the liabilities of Zymeworks can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Zymeworks?
Some factors that can influence the liabilities of Zymeworks include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Zymeworks so important for investors?
The liabilities of Zymeworks are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Zymeworks take to modify the liabilities?
To change its liabilities, Zymeworks can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Zymeworks pay?
Over the past 12 months, Zymeworks paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zymeworks is expected to pay a dividend of 0 USD.
What is the dividend yield of Zymeworks?
The current dividend yield of Zymeworks is .
When does Zymeworks pay dividends?
Zymeworks pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Zymeworks?
Zymeworks paid dividends every year for the past 0 years.
What is the dividend of Zymeworks?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Zymeworks located?
Zymeworks is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zymeworks kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zymeworks from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.
When did Zymeworks pay the last dividend?
The last dividend was paid out on 10/1/2024.
What was the dividend of Zymeworks in the year 2023?
In the year 2023, Zymeworks distributed 0 USD as dividends.
In which currency does Zymeworks pay out the dividend?
The dividends of Zymeworks are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zymeworks
Our stock analysis for Zymeworks Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zymeworks Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
